Log In
Print this Print this

GZ/SAR402671, GZ402671

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionGlucosylceramide synthase (GCS) inhibitor
Molecular Target Glucosylceramide synthase (GCS)
Mechanism of ActionGlucosylceramide synthase (GCS) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation U.S. - Fast Track (Treat Fabry's disease)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today